Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

27 avr. 2015 08h31 HE | Source: iBio, Inc.

iBio Arranges Production of IBIO-CFB03 for Clinical Development With Caliber Biotherapeutics

NEWARK, DE--(Marketwired - Apr 27, 2015) - iBio, Inc. (NYSE MKT: IBIO), has engaged Caliber Biotherapeutics LLC to scale-up and produce materials for clinical development of the first of iBio's...
30 mars 2015 08h31 HE | Source: iBio, Inc.

iBio European Plague Vaccine Patent Emerges From Opposition Period

NEWARK, DE--(Marketwired - Mar 30, 2015) - iBio, Inc. (NYSE MKT: IBIO), today announced it received notice from the European Patent Office that the opposition period expired for a bio-defense...
25 févr. 2015 08h31 HE | Source: iBio, Inc.

iBio Adds Anthrax Antibodies to Product Pipeline

NEWARK, DE--(Marketwired - Feb 25, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of US...
12 févr. 2015 08h31 HE | Source: iBio, Inc.

iBio Receives US and European Patents for Protein Expression Technology

NEWARK, DE--(Marketwired - Feb 12, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issuance of...
04 févr. 2015 08h31 HE | Source: iBio, Inc.

iBio Adds to iBioModulator Portfolio and Product Pipeline

NEWARK, DE--(Marketwired - Feb 4, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of a new...
10 déc. 2014 08h31 HE | Source: iBio, Inc.

iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate and Other Activities for the 2014 Annual Shareholders Meeting

NEWARK, DE--(Marketwired - Dec 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in biotechnology for developing and manufacturing plant-made pharmaceutical products, will provide shareholders and...
10 nov. 2014 08h31 HE | Source: iBio, Inc.

iBio Grants Caliber License for Production of Antibodies Targeting Ebola

NEWARK, DE--(Marketwired - Nov 10, 2014) - iBio, Inc. (NYSE MKT: IBIO) and Caliber Biotherapeutics LLC executed an agreement, effective today, for an emergency use license to the iBioLaunch™...
22 oct. 2014 08h31 HE | Source: iBio, Inc.

iBio Expands Exclusive Product Collaboration With Novici Biotech

NEWARK, DE--(Marketwired - Oct 22, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, and Novici Biotech LLC...
16 oct. 2014 08h31 HE | Source: iBio, Inc.

iBio Responds to Inquiries About its Role in Emergency Response to Ebola Virus Disease Outbreak

NEWARK, DE--(Marketwired - Oct 16, 2014) - iBio, Inc. (NYSE MKT: IBIO) today confirmed, in response to shareholder and media inquiries: (i) the applicability of its issued U.S. iBioLaunch™...
03 oct. 2014 17h00 HE | Source: iBio, Inc.

iBio Reports on Filing of 2014 Annual Report

NEWARK, DE--(Marketwired - Oct 3, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced, as required...

Page précédente